Product Data Sheet

Acipimox-d4

Catalog No. B13221

main product photo
Acipimox-d4 is a deuterium-labeled analogue of Acipimox, a compound known for its antilipolytic properties. This stable isotope effectively inhibits lipolysis, leading to reduced systemic levels of free fatty acids (FFAs) and enhanced insulin sensitivity. Acipimox-d4 is valuable in research applications focused on metabolism, lipid regulation, and diabetes studies.
Chemical Information
Catalog NumB13221
M. Wt158.15
FormulaC6H2D4N2O3
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.1246816-28-3
SynonymsK-9321-d4
SMILES[2H]C(C1=CN=C(C(O)=O)C([2H])=[N+]1[O-])([2H])[2H]
Biological Activity
DescriptionAcipimox-d4 is a deuterium-labeled analogue of Acipimox, a compound known for its antilipolytic properties. This stable isotope effectively inhibits lipolysis, leading to reduced systemic levels of free fatty acids (FFAs) and enhanced insulin sensitivity. Acipimox-d4 is valuable in research applications focused on metabolism, lipid regulation, and diabetes studies.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.